List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 125 studies with search of: Biliary Tract Neoplasms
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Malignant Obstruction ZILVER Against Routine Therapy (MOZART I)
Conditions: Biliary Tract Neoplasms;   Pancreatic Neoplasms;   Jaundice, Obstructive
Intervention: Device: Zilver biliary endoprostheses
2 Completed EXIBIT: Oxaliplatin in Biliary Tract Cancer
Condition: Biliary Tract Neoplasms
Intervention: Drug: oxaliplatin
3 Not yet recruiting A Randomised Phase II/III Study of Cediranib (AZD2171) or Placebo in Combination With Cisplatin/Gemcitabine for Patients With Advanced Biliary Tract Cancers
Condition: Biliary Tract Neoplasms
Interventions: Drug: gemcitabine;   Drug: cisplatin;   Drug: Placebo;   Drug: cediranib
4 Active, not recruiting The Efficacy and Safety of Gemcitabine in Combination With Docetaxel to Treat Pancreatic or Biliary Cancer
Conditions: Pancreatic Neoplasms;   Biliary Tract Neoplasms
Interventions: Drug: Docetaxel;   Drug: Gemcitabine
5 Recruiting Comparing Endoscopic Based Stent Strategy Versus Bypass Surgery in Non-Resectable Periampullary Cancer
Conditions: Pancreatic Neoplasms;   Biliary Tract Neoplasms;   Duodenal Neoplasms
Interventions: Procedure: surgery;   Procedure: endoscopic strategy
6 Recruiting A Randomized Trial of Two Surgical Techniques for Pancreaticojejunostomy in Patients Undergoing Pancreaticoduodenectomy
Conditions: Pancreatic Neoplasms;   Biliary Tract Neoplasms;   Pancreatitis, Chronic;   Duodenal Neoplasms
Intervention: Procedure: pancreaticojejunostomy
7 Recruiting Endoscopic Stenting of Gastrointestinal Cancer
Conditions: Gastrointestinal Neoplasms;   Biliary Tract Neoplasms
Intervention: Procedure: Endoscopic stenting
8 Recruiting RCT Steel (Wallstent®) vs Nitinol (Wallflex®) Bile Duct Stent for Palliation of Malignant Obstruction
Conditions: Biliary Tract Neoplasms;   Pancreatic Neoplasms;   Stents
Interventions: Device: Patency of Steel Stent.;   Device: Patency of Nitinol Stent, Wallflex®.
9 Terminated XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary Tumors
Condition: Biliary Tract Cancer
Interventions: Drug: becatecarin;   Drug: 5-Fluorouracil Plus Leucovorin
10 Active, not recruiting Bevacizumab and Erlotinib in Treating Patients With Metastatic or Unresectable Biliary Tumors
Conditions: Extrahepatic Bile Duct Cancer;   Gallbladder Cancer
Interventions: Biological: bevacizumab;   Drug: erlotinib hydrochloride;   Genetic: molecular diagnostic method;   Genetic: mutation analysis;   Genetic: protein expression analysis;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis
11 Active, not recruiting A Registry of Patients Undergoing Cellvizio Endomicroscopy and Endoscopic Retrograde Cholangiopancreatography(ERCP) Imaging Procedures for Diagnosing Pancreatic and Bile Duct Cancers
Conditions: Pancreatic Cancer;   Bile Duct Cancer
Intervention: Device: Probe-based confocal laser endomicroscopy
12 Recruiting Vandetanib Gemcitabine Or Placebo Plus Gemcitabine Or Vandetanib Monotherapy In Advanced Biliary Tract Cancer
Conditions: Biliary Tract Cancer;   Gallbladder Cancer;   Cancer Of The Extrahepatic Bile Duct;   Ampullary Carcinoma
Interventions: Drug: ZD6474, VANDETANIB;   Drug: GEMCITABINE;   Drug: Placebo matching ZD6474
13 Active, not recruiting Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.
Conditions: Ovarian;   Melanoma;   Renal;   Prostate;   Colorectal;   Endometrial Carcinoma;   Cervical Carcinoma;   Testicular Cancer;   Thyroid Cancer;   Small Cell Lung Carcinoma;   Mesothelioma;   Breast Carcinoma;   Esophageal Carcinoma;   Gastric Cancer;   Pancreatic Carcinoma;   Neuroendocrine Cancer;   Liver Cancer;   Gallbladder Cancer;   Biliary Tract Cancer;   Anal Carcinoma;   Bone Sarcomas;   Soft Tissue Sarcomas;   Carcinoma of Unknown Origin, Primary
Intervention: Biological: PSMA/PRAME
14 Recruiting A Study of Combination of Gemcitabine, Oxaliplatin (GEMOX)-Sorafenib in Patients With Advanced Biliary Tract Cancer
Conditions: Cholangiocarcinoma;   Biliary Tract Cancer;   Gallbladder Cancer
Interventions: Drug: Gemcitabine;   Drug: Oxaliplatin;   Drug: Sorafenib
15 Completed Gemcitabine and Cisplatin for Gallbladder and Biliary Tract Cancer
Conditions: Gallbladder Cancer;   Biliary Tract Cancer
Interventions: Drug: Gemcitabine;   Drug: Cisplatin
16 Active, not recruiting Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Patients With Biliary Tract and Gallbladder Cancer
Conditions: Biliary Tract Cancer;   Gallbladder Adenocarcinoma
Interventions: Drug: Capecitabine;   Drug: Oxaliplatin;   Drug: Bevacizumab;   Procedure: Radiation therapy
17 Completed
Has Results 		Randomized Phase 2 Study With Gemcitabine Alone and Combination Therapy for Patients With Advanced Biliary Tract Cancer
Condition: Biliary Tract Cancer
Interventions: Drug: gemcitabine;   Drug: cisplatin
18 Completed A Population-Based Case-Control Study of Biliary Tract Cancers in Shanghai, China
Condition: Biliary Tract Cancer
Intervention:
19 Completed Oxaliplatin and Capecitabine in Patients With Unresectable Cholangiocarcinoma
Conditions: Cancer of the Gallbladder;   Cancer of the Biliary Tract
Interventions: Drug: Capecitabine;   Drug: Oxaliplatin
20 Recruiting Storage of Bile From Routine Procedures to Study Risk Factors
Conditions: Gallbladder Cancer;   Cholangiocarcinoma;   Biliary Tract Cancer
Intervention:

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services